Leslie R Boyd

Biosketch / Results /

Leslie R Boyd, M.D.

Assistant Professor;
Department of Obstetrics and Gynecology (Obs/Gyn)

Clinical Addresses

240 EAST 38TH STREET
19TH FLOOR
NEW YORK, NY 10016
Handicap Access: yes
Phone: 212-731-6430
Fax: 212-731-5600

« Back to Results

Medical Specialties

Cancer, Obstetrics/Gynecology, Gynecology

Medical Expertise

Endometrial Ablation, Gynecologic Cancers, Gynecologic Surgery, Gynecologic Oncology, Gynecologic Robotic Surgery, Cervical Cancer, Uterine Cancer, Vaginal Cancer, Robotic Surgery, Ovarian Cancer

Clinical Responsibilities

I am accepting new patients. New patients should call the NEW PATIENT REFERRAL LINE at 212-731-6066

Insurance

AETNA HMO, AETNA INDEMNITY, AETNA MEDICARE, AETNA POS, AETNA PPO/EPO, AFFINITY, AFFINITY EXCHANGE- ESSENTIAL, Cigna HMO/POS, Cigna PPO, EBCBS EPO, EBCBS HLTHY NY, EBCBS HMO, EBCBS INDEMNITY, EBCBS MEDIBLUE, EBCBS POS, EBCBS PPO, GHI CBP, HEALTHPLUS CHLD HLTH (AMERIGROUP), HEALTHPLUS FAM HLTH (AMERIGROUP), HEALTHPLUS MEDICAID (AMERIGROUP), HEALTHREPUBLIC, HIP ACCESS I, HIP ACCESS II, HIP CHLD HLTH, HIP EPO/PPO, HIP FAM HLTH, HIP HMO, HIP MEDICAID, HIP MEDICARE, HIP POS, LOCAL 1199 PPO, MAGNACARE PPO, MULTIPLAN/PHCS PPO, Medicare, NYS EMPIRE PLAN, OSCAR, OXFORD EXCHANGE, OXFORD FREEDOM, Oxford Liberty, Oxford Medicare, Tricare, UHC COMMUNITY & STATE PLAN, UHC EPO, UHC HMO, UHC MEDICARE, UHC POS, UHC PPO, UNITED EXCHANGE- COMPASS

Insurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.

« Back to Results

Board Certification

2007 — Ab Obstetrics & Gynecology - Obstetrics & Gynecology

Education

1996-2000 — Yale University School of Medicine, Medical Education
2000-2001 — NYU Langone Medical Center (Obstetrics & Gynecol), Internship
2001-2004 — NYU Langone Medical Center (Obsterics/Gynecology), Residency Training
2006-2009 — NYU Langone Medical Center (Gynecologic Oncology), Clinical Fellowships

« Back to Results

All data from NYU Health Sciences Library Faculty Bibliography — -

Contact:
http://hsl.med.nyu.edu/faculty-bibliography-search

Trial design and endpoint definition for conservative management of endometrial neoplasia
Blank, S; Greenwald, J; Boyd, L; Pothuri, B; Curtin, J
2013 July 2013;Conference:(44th):e66-, Gynecologic oncology
— id: 452962, year: 2013, vol: Conference:, page: e66, stat: Journal Article,

Outcomes for High-Dose-Rate (HDR) Brachytherapy in the Treatment of Cervical Cancer
Chin, M. ; Mm, C. ; Sethi, R. ; Formenti, S. C. ; Jozsef, G. ; Blank, S. V. ; Pothuri, B. ; Boyd, L. R. ; Schiff, P. B.
2013 OCT 1;87(2 S S):S406-S406, International journal of radiation oncology biology physics
— id: 657482, year: 2013, vol: 87, page: S406, stat: Journal Article,

Combination of irinotecan and bevacizumab for heavily pretreated recur-rent ovarian cancer: A phase II trial
Ling, H; Muggia, F; Speyer, J; Curtin, J; Blank, S; Boyd, L; Pothuri, B; Li, X; Goldberg, J; Tiersten, A
2013 July 2013;Conference:(44th):e12-, Gynecologic oncology
— id: 452992, year: 2013, vol: Conference:, page: e12, stat: Journal Article,

Best practices in risk-reducing bilateral salpingo-oophorectomy: The influence of surgical specialty
Malacarne, D; Long, Y; Boyd, L; Wallach, R; Pothuri, B; Fishman, D; Curtin, J; Blank, S
2013 July 2013;Conference:(44th):e102-, Gynecologic oncology
— id: 452952, year: 2013, vol: Conference:, page: e102, stat: Journal Article,

Advanced endometrial cancer: Is there a benefit to neoadjuvant therapy?
Czok, S; Zechmeister, J R; Jewell, A; Boyd, L R
2012 20 May 2012;30(15):-, Journal of clinical oncology
— id: 249902, year: 2012, vol: 30, page: , stat: Journal Article,

Phase II trial of irinotecan plus bevacizumab for heavily pretreated recurrent ovarian cancer
Jain, S S; Makeyev, Y G; Muggia, F; Speyer, J L; Curtin, J P; Blank, S V; Boyd, L R; Pothuri, B; Fishman, D; Li, X; Goldberg, J D; Tiersten, A
2012 20 May 2012;30(15):-, Journal of clinical oncology
— id: 250082, year: 2012, vol: 30, page: , stat: Journal Article,

Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer
Verschraegen, C F; Czok, S; Muller, C Y; Boyd, L; Lee, S J; Rutledge, T; Blank, S; Pothuri, B; Eberhardt, S; Muggia, F
2012 Dec;23(12):3104-3110, Annals of oncology
— id: 205202, year: 2012, vol: 23, page: 3104, stat: Journal Article,

CA-125 surveillance for women with ovarian, fallopian tube or primary peritoneal cancers: What do survivors think?
Boyd, L.; Bedell, S.; Curtin, J.; Wallach, R.; Pothuri, B.; Muggia, F.; Tiersten, A.; Blank, S.
2011 MAR ;121(1):S64-S64, Gynecologic oncology
— id: 132764, year: 2011, vol: 121, page: S64, stat: Journal Article,

Ovarian cancer care for the underserved: are surgical patterns of care different in a public hospital setting?
Boyd, Leslie R; Novetsky, Akiva P; Curtin, John P
2011 Feb 15;117(4):777-783, Cancer
— id: 138235, year: 2011, vol: 117, page: 777, stat: Journal Article,

Pegylated liposomal doxorubicin with bevacizumab in the treatment of platinum-resistant ovarian cancer: Toxicity profile results
Czok, S.; Jewell, A.; Shawki, S.; Boyd, L.; Smith, H.; Blank, S.; Muller, C.; Verschraegen, C.; Muggia, F.
2011 MAR ;121(1):S83-S83, Gynecologic oncology
— id: 132765, year: 2011, vol: 121, page: S83, stat: Journal Article,

Trends in bilateral oophorectomy at the time of hysterectomy for benign disease
Novetsky, Akiva P; Boyd, Leslie R; Curtin, John P
2011 Dec;118(6):1280-1286, Obstetrics & gynecology
— id: 141713, year: 2011, vol: 118, page: 1280, stat: Journal Article,

Incidental gynecologic FDG-PET/CT findings in women with a history of breast cancer
Pua, T.; Jewell, A.; Novetsky, A.; Lee, J.; Friedman, K.; Whyte, J.; Boyd, L.; Pothuri, B.; Curtin, J.; Blank, S.
2011 MAR ;121(1):S62-S62, Gynecologic oncology
— id: 132763, year: 2011, vol: 121, page: S62, stat: Journal Article,

BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicin
Safra T; Lucia B; Nicoletto MO; Rolnitzky L; Pelles-Avraham S; Geva R; Donach ME; Curtin J; Novetsky A; Grenader T; Lai WC; Gabizon AA; Boyd L; Muggia FM
2011 Oct;10(10):2000-2007, Molecular cancer therapeutics
— id: 136569, year: 2011, vol: 10, page: 2000, stat: Journal Article,

Effect of surgical volume on route of hysterectomy and short-term morbidity
Boyd, Leslie R; Novetsky, Akiva P; Curtin, John P
2010 Oct;116(4):909-915, Obstetrics & gynecology
— id: 112564, year: 2010, vol: 116, page: 909, stat: Journal Article,

A comparison of postoperative pain between robotic and laparoscopic gynecologic surgery
Ferrante, K; Novetsky, A; Pua, T; Jain, R; Boyd, L; Blank, S; Curtin, J; Pothuri, B
2010 MAR ;116(3):S148-S148, Gynecologic oncology
— id: 111930, year: 2010, vol: 116, page: S148, stat: Journal Article,

Weekly Paclitaxel with intermittent imatinib mesylate (gleevec(r)>): tolerance and activity in recurrent epithelial ovarian cancer
Safra, Tamar; Andreopoulou, Eleni; Levinson, Benjamin; Borgato, Lucia; Pothuri, Bhavana; Blank, Stephanie; Tiersten, Amy; Boyd, Leslie; Curtin, John; Muggia, Franco
2010 Sep;30(9):3243-3247, Anticancer research
— id: 113816, year: 2010, vol: 30, page: 3243, stat: Journal Article,

Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity
Wang, Feng-qiang; Ariztia, Edgardo V; Boyd, Leslie R; Horton, Faith R; Smicun, Yoel; Hetherington, Jessica A; Smith, Phillip J; Fishman, David A
2010 Apr;117(1):88-95, Gynecologic oncology
— id: 133487, year: 2010, vol: 117, page: 88, stat: Journal Article,

Ovarian cancer treatment in the New York City municipal hospital system
Boyd L.R.; Novetsky A.P.; Curtin J.P.
2009 ;27(15 Suppl 1):5569-5569, Journal of clinical oncology
— id: 111801, year: 2009, vol: 27, page: 5569, stat: Journal Article,

Epidemiology and treatment of cervical cancer cases in a private versus public hospital setting
Boyd, LR; Pua, TL; Novetsky, AP; Pothuri, B; Curtin, JP; Hope, JM; Wallach, RC; Fishman, DA; Blank, SV
2009 FEB ;112(2):S44-S44, Gynecologic oncology
— id: 97670, year: 2009, vol: 112, page: S44, stat: Journal Article,

Lysophosphatidic acid receptor-2 mediates lysophosphatidic acid-induced endometrial cancer invasion
Hope, JM; Wang, F; Whyte, JS; Boyd, LR; Ariztia, EV; Long, K; Fishman, DA
2009 FEB ;112(2):S79-S79, Gynecologic oncology
— id: 97673, year: 2009, vol: 112, page: S79, stat: Journal Article,

Outcomes of endometrial cancer cases in a private versus public hospital setting
Pua, TL; Boyd, LR; Novetsky, AP; Garcia, L; Devine, K; Curtin, JP; Pothuri, B; Hope, JM; Wallach, RC; Fishman, DA; Blank, SV
2009 FEB ;112(2):S82-S83, Gynecologic oncology
— id: 97674, year: 2009, vol: 112, page: S82, stat: Journal Article,

Endometrial cancer cells treated with lysophosphatidic acid increase activation of matrix metalloproteinase 2
Boyd, LR; Ariztia, EV; Mayer-Hope, J; Fishman, DA
2008 MAR ;108(3):S89-S89, Gynecologic oncology
— id: 76431, year: 2008, vol: 108, page: S89, stat: Journal Article,

Endometrial cancer cells produce proinvasive vesicles
Boyd, LR; Mayer-Hope, J; Ariztia, EV; Fishman, DA
2008 MAR ;108(3):S75-S76, Gynecologic oncology
— id: 76430, year: 2008, vol: 108, page: S75, stat: Journal Article,